GNCC Capital, Inc. through its subsidiary, BioCann Pharma S.A.S., produces and sells cannabis CBD pharmaceutical grade oils. It sells its products through distribution channels in Colombia and throughout Latin America. The company is based in Las Vegas, Nevada.
Stock data | 2024 | Change |
---|---|---|
Price | $0.00001 | N/A |
Market Cap | $1.24M | N/A |
Shares Outstanding | 124.11B | N/A |
Employees | 0 | N/A |